AURA compared with LXEO: revenue, margins and what each company keeps, and the suppliers and customers both name

AURAAura Biosciences, Inc.

Mkt capRevenueRevenue

LXEOLexeo Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AURAAura Biosciences, Inc.

LXEOLexeo Therapeutics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closes · 500dMethod ›

Moved together

AURAwithLXEO

×0.51co-movement · LXEO on AURA · 500d

r 0.28scale to r 0.75

Shared co-movers3with AURAwith LXEO

CLDXCelldex Therapeutics, Inc.r 0.40r 0.37

DYNDyne Therapeutics, Inc.r 0.39r 0.36

MGTXMeiraGTx Holdings plcr 0.43r 0.36

AURA, solidLXEO, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

AURAAura Biosciences, Inc.

6.14▼−2.46%· post 6.14

Mkt cap$636.7M

LXEOLexeo Therapeutics, Inc.

3.14▲+2.61%· post 3.14

ClosedOct 30 '26

Mkt cap$257.6M

Compare

ClosedOct 30 '26

AURAAura Biosciences, Inc.

LXEOLexeo Therapeutics, Inc.

6.14▼−2.46%post 6.14

Price

3.14▲+2.61%post 3.14

$636.7M

Mkt cap

$257.6M

AURA6.14▼−2.46%vsLXEO3.14▲+2.61%ClosedOct 30 '26